NC(=O)c1nsc(C(=O)N(c2cccc(F)c2)C(C(=O)NC2CCCC2)c2ccco2)c1N
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?